Pitcairn Co. Has $9.35 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pitcairn Co. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,905 shares of the medical equipment provider's stock after selling 873 shares during the quarter. Intuitive Surgical comprises about 0.6% of Pitcairn Co.'s portfolio, making the stock its 25th biggest position. Pitcairn Co.'s holdings in Intuitive Surgical were worth $9,346,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of the stock. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical during the fourth quarter worth $28,000. Summit Securities Group LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $31,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 3.3 %

Shares of ISRG traded up $14.86 during mid-day trading on Monday, hitting $466.44. 2,970,272 shares of the company's stock were exchanged, compared to its average volume of 1,549,408. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock's 50-day simple moving average is $545.18 and its 200-day simple moving average is $533.00. The firm has a market cap of $166.14 billion, a price-to-earnings ratio of 72.10, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Remove Ads

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ISRG. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, March 18th. CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price for the company. Erste Group Bank downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Truist Financial reduced their price target on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a research report on Monday, March 17th. Finally, Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $611.86.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 269 shares of the company's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last 90 days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.